Concomitant HIV and mycobacterial infection in Ireland, 1987-92

L M Mundy1, M M Lynch, B D Crowley

  • 1Department of Genitourinary Medicine, St James's Hospital, Dublin, Ireland.

Insights

This study found an increasing trend of mycobacterial infections in HIV patients in Ireland, with a higher rate of non-tuberculous mycobacteria (MOTT) and poorer survival compared to Mycobacterium tuberculosis.

Area of Science:

  • Infectious Diseases
  • Public Health
  • HIV/AIDS Research

Background:

  • Human Immunodeficiency Virus (HIV) infection significantly increases susceptibility to opportunistic infections, including mycobacterial diseases.
  • Mycobacterial infections, both Mycobacterium tuberculosis (M.tb) and mycobacteria other than tuberculosis (MOTT), pose a substantial health burden in HIV-positive individuals.
  • Previous studies indicated a lower prevalence of MOTT in Ireland compared to other regions.

Purpose of the Study:

  • To analyze the trends and characteristics of concomitant HIV and mycobacterial infections in the Republic of Ireland over a six-year period.
  • To compare the incidence and outcomes of Mycobacterium tuberculosis versus MOTT infections in HIV-infected patients.
  • To identify risk factors and patient demographics associated with these infections.

Main Methods:

  • A retrospective review of culture-proven mycobacterial infections in HIV-infected patients was conducted.
  • Data collected included patient demographics, infection type (M.tb vs. MOTT), risk factors (e.g., homosexual activity, intravenous drug use, incarceration), treatment compliance, and patient survival.
  • Statistical analysis, including log-rank test, was used to compare survival rates.

Main Results:

  • A total of 42 mycobacterial infections were identified in 40 HIV-infected patients.
  • There was a significant increase in MOTT infections compared to historical data, with an overall 4-fold rise in detection rates between 1987 and 1992.
  • MOTT infections were more common in homosexual individuals, while M.tb predominated in intravenous drug users (IVDUs). Non-compliance led to tuberculosis relapse and drug resistance.
  • One-year survival rates were significantly lower for MOTT infections (36%) compared to M.tb infections (79%).

Conclusions:

  • The incidence of mycobacterial infections, particularly MOTT, is rising among HIV-infected individuals in Ireland.
  • Treatment compliance is critical for preventing tuberculosis relapse and the development of drug-resistant strains.
  • Mycobacterium tuberculosis infections have a better prognosis than MOTT infections in this patient population, highlighting the need for targeted management strategies.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...